| Bioactivity | Virginiamycin M1 (Pristinamycin IIA; Ostreogrycin A), produced by Streptomyces virginiae, is an polyunsaturated macrocyclic lactone antibiotic and acts as a component of Virginiamycin (HY-112665)[1]. Virginiamycin M1 alone is against Staphylococcus aureus with a MIC of 0.25 μg/mL. The combination of Virginiamycin M1 and Virginiamycin S1 (HY-N6680) is 0.125 μg/mL (MIC Value), which can improve the bactericidal effect 1-30 times[2]. | ||||||||||||
| Name | Virginiamycin M1 | ||||||||||||
| CAS | 21411-53-0 | ||||||||||||
| Formula | C28H35N3O7 | ||||||||||||
| Molar Mass | 525.59 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
Virginiamycin M1
CAS: 21411-53-0 F: C28H35N3O7 W: 525.59
Virginiamycin M1 (Pristinamycin IIA; Ostreogrycin A), produced by Streptomyces virginiae, is an polyunsaturated macrocy
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.